As of Aug 31
| +3.00 / +8.46%|
The 6 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 41.00, with a high estimate of 47.00 and a low estimate of 38.00. The median estimate represents a +6.60% increase from the last price of 38.46.
The current consensus among 6 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.